Sign in
WithdrawnPhase 1

Cardiac Perfusion and Metabolism With [11C] Acetate PET/CT is Associated With Hematopoietic System Activation in Acute Decompensated Heart Failure: An Imaging Sub-study

Key facts

Who runs it
University of Alabama at Birmingham
Where
Birmingham, United StatesSee the site
Trial code
Status
Withdrawn
Phase
Phase 1
Started
31 Dec 2025
Ended
31 Oct 2026
Type of study
Interventional
Treatments tested
  • Cardiac Perfusion and Metabolism with [11C] Acetate PET/CT
Record updated
7 April 2023
Why it stopped
The study was not able to enroll any eligible subjects.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • At least 18 years of age
  • Enrollment in the UAB CMC-ADHF study under the separate UAB approved research protocol (IRB-300000114, PI Rajapreyar)
  • Negative urine or serum β-hCG test within 48 hours of [11C] acetate administration in women of child bearing potential. Women who are post-menopausal with at least 1 year since last menses or documented surgical sterilization will not require pregnancy testing

Who cannot take part

  • Inability to provide informed consent
  • Pregnancy
  • Inability to lie still for the imaging study
  • Weight exceeding the weight limit of the PET imaging table (500 pounds)

Where in United States

  • University of Alabama at Birmingham Medical CenterBirmingham, United States

About the trial

What the trial wants to find out

The purpose of this sub-study is to use positron emission tomography and computed tomography imaging (PET/CT) with an investigational drug called [11C] acetate to see if inflammation in patients with acute decompensated heart failure (ADHF) can cause changes in blood flow and oxygen use in the heart. This study may help physicians better understand how to treat patients diagnosed with ADHF in the future.

The group in the trial

  • patients with acute decompensated systolic and diastolic heartTreatment being tested

    Treatment: Cardiac Perfusion and Metabolism with [11C] Acetate PET/CT

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
7 April 2023